Australia markets closed

Harmony Biosciences Holdings, Inc. (HRMY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.17-1.31 (-4.16%)
At close: 04:00PM EDT
30.15 -0.02 (-0.07%)
After hours: 05:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.71B
Enterprise value 1.53B
Trailing P/E 13.00
Forward P/E 20.79
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.91
Price/book (mrq)3.32
Enterprise value/revenue 2.48
Enterprise value/EBITDA 6.53

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-13.40%
S&P500 52-week change 322.55%
52-week high 339.26
52-week low 318.61
50-day moving average 329.92
200-day moving average 330.37

Share statistics

Avg vol (3-month) 3400.29k
Avg vol (10-day) 3503.74k
Shares outstanding 556.79M
Implied shares outstanding 656.79M
Float 834.64M
% held by insiders 119.77%
% held by institutions 191.88%
Shares short (14 June 2024) 48.13M
Short ratio (14 June 2024) 429.27
Short % of float (14 June 2024) 464.07%
Short % of shares outstanding (14 June 2024) 414.31%
Shares short (prior month 15 May 2024) 47.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.30%
Operating margin (ttm)33.65%

Management effectiveness

Return on assets (ttm)16.30%
Return on equity (ttm)28.73%

Income statement

Revenue (ttm)617.51M
Revenue per share (ttm)10.52
Quarterly revenue growth (yoy)29.80%
Gross profit (ttm)N/A
EBITDA 228.06M
Net income avi to common (ttm)137.7M
Diluted EPS (ttm)2.32
Quarterly earnings growth (yoy)30.00%

Balance sheet

Total cash (mrq)372.35M
Total cash per share (mrq)6.56
Total debt (mrq)193.06M
Total debt/equity (mrq)37.46%
Current ratio (mrq)3.11
Book value per share (mrq)9.07

Cash flow statement

Operating cash flow (ttm)207.97M
Levered free cash flow (ttm)202.42M